Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multidrug-resistance transporters.

J A Silverman1

  • 1AvMax, Inc., South San Francisco, CA 94080, USA.

Pharmaceutical Biotechnology
|April 1, 2000
PubMed
Summary
This summary is machine-generated.

P-glycoprotein (P-gp) is crucial for drug pharmacokinetics and multidrug resistance. Modulating P-gp function impacts drug bioavailability but may cause adverse effects due to its widespread tissue distribution.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.

Alimentary pharmacology & therapeutics·2016
Same author

Enhanced bioavailability of oral docetaxel by co-administration of cyclosporin A in dogs and rats.

Veterinary and comparative oncology·2009
Same author

Sir William Gull (1819-1890). Limner of anorexia nervosa and myxoedema. An historical essay and encomium.

Eating and weight disorders : EWD·2003
Same author

The development of marked elevation in white blood cell count does not predict inferior outcome in chronic lymphocytic leukemia.

Leukemia & lymphoma·2002
Same author

Resistance studies with daptomycin.

Antimicrobial agents and chemotherapy·2001
Same author

Reverse engineering the (beta/alpha )8 barrel fold.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same journal

Formulation development of protein dosage forms.

Pharmaceutical biotechnology·2002
Same journal

Regulatory considerations in the development of protein pharmaceuticals.

Pharmaceutical biotechnology·2002
Same journal

Quality assurance and quality control for biopharmaceutical products.

Pharmaceutical biotechnology·2002
Same journal

Fundamentals of freeze-drying.

Pharmaceutical biotechnology·2002
Same journal

Membrane filtration.

Pharmaceutical biotechnology·2002
Same journal

Fundamentals of thermal sterilization processes.

Pharmaceutical biotechnology·2002
See all related articles

Area of Science:

  • Pharmacology
  • Biochemistry
  • Molecular Biology

Background:

  • P-glycoprotein (P-gp) was first identified for its role in multidrug resistance in cancer chemotherapy.
  • Emerging research highlights P-gp's significant involvement in the pharmacokinetics of various drugs.
  • P-gp is strategically located in tissues critical for drug absorption and disposition, including the intestinal mucosa, liver, kidneys, and blood-brain barrier.

Purpose of the Study:

  • To elucidate the role of P-glycoprotein in drug pharmacokinetics and multidrug resistance.
  • To explore the potential of modulating P-gp function for enhancing therapeutic effectiveness.
  • To assess the potential consequences of P-gp inhibition or modulation.

Main Methods:

  • Review of existing literature on P-glycoprotein function and drug interactions.

Related Experiment Videos

  • Analysis of studies involving P-gp substrates like digoxin, cyclosporine, and various chemotherapeutics.
  • Examination of data from P-gp-deficient animal models.

    • Main Results:

    • P-glycoprotein significantly influences the absorption, distribution, and elimination of numerous drugs.
    • Pharmacological modulation of P-gp can alter drug bioavailability and therapeutic outcomes.
    • P-gp deficiency in animal models leads to altered pharmacokinetics and increased drug toxicity.

    Conclusions:

    • P-glycoprotein plays a vital role in drug pharmacokinetics and represents a key factor in multidrug resistance.
    • Targeting P-gp for therapeutic benefit requires careful consideration of its broad physiological functions and potential adverse effects.
    • Further research into P-gp and other multidrug transporters is essential for drug development and optimizing treatment strategies.